GSK Pharmaceuticals' operation revenue in India FY 2014-2023

Published by A. Minhas, Aug 11, 2023
The revenue from operations for GSK Pharmaceuticals Limited in fiscal year 2023 was 32.16 billion Indian rupees. This was a slight decrease in revenue compared to the previous financial year. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.

Revenue from operations of GSK Pharmaceuticals Limited in India from financial year 2014 to 2023 (in billion Indian rupees)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2023

Region

India

Survey time period

FY 2014 to FY 2023

Supplementary notes

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

One Indian rupee is equal to 0.011 euros and 0.012 U.S. dollars (as of August 2023).

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India

Market overview

6

GSK India - key figures

6

Product portfolio

3

Main competitiors

4

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu